Project Grant R03HD113500
Award Date
9/6/23
Completion Date
8/31/25
Dollars Obligated
$158K
Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Illinois, USA
Similar Awards
This federal Project Grant award under the Child Health and Human Development Extramural Research program (CFDA 93.865) at the National Institute of Child Health and Human Development will support research on the impact of dolutegravir (DTG)-based antiretroviral therapy (ART) regimens on appetite regulation and weight management in postpartum women living with HIV and their HIV-exposed uninfected (HEU) infants. The total funding amount is $262,105 for the project period from August 6, 2024 to...
This $756,077 Project Grant was awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports a 5-year research study to investigate the long-term immunologic, cardiovascular, metabolic, and neurocognitive outcomes in children and adolescents with perinatal HIV infection who have achieved viral suppression on long-term antiretroviral therapy. The research will assess...
The federal Project Grant award R21HD118590, in the amount of $232,500.00, was provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The project aims to investigate the virologic determinants that lead to the formation of the viral reservoir in infants with in utero HIV-1 transmission, with a focus on examining sex differences in HIV-1 replication capacity and interferon resistance....
The U.S. National Institute of Child Health and Human Development (NICHD) awarded a $1,376,850 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate interventions for protecting HIV-exposed uninfected infants against severe infections. The project aims to define the relationship between the infant gut microbiome, immune functions, and metabolomic profiles in this population, as well as test dietary interventions to modulate the gut...
This federal Project Grant award, totaling $259,818, was provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award will support research to (1) characterize barriers to adherence for pediatric dolutegravir combination therapy and (2) estimate per-protocol effects of treatment failure by 96 weeks in the ODYSSEY pediatric HIV trial. The research will leverage modern causal...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $244,328 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH). The funding will support research to investigate the impact of in utero HIV and antiretroviral (ARV) exposure on the placenta and birth weight. Specifically, the research aims to: 1) Compare histologic placental abnormalities by ARV...
This $158,216 Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will support a longitudinal study on the effects of prenatal exposure to maternal incarceration on infant and toddler health and development. The research will analyze data from the "Birth Beyond Bars" study to assess the impact of environmental factors before and during maternal...
This $273,424 Project Grant was awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports research to determine if HIV-1 exposed infants passively immunized with broadly neutralizing antibodies (bNABs) in the IMPAACT P1112 trial achieved high serum neutralization titers against HIV-1 viruses transmitted through breastmilk. The research aims to evaluate if a biomarker...
This federal Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) provides $534,721 to Oregon Health & Science University to study the impact of antiretroviral therapy (ART) on fetal immune system development in a rhesus macaque model of simian immunodeficiency virus (SIV) infection. The research aims to determine the effects of maternal SIV/ART or ART alone on fetal immune system function...
The National Institute of Child Health and Human Development (NICHD) awarded a $161,000 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to The Research Foundation for the State University of New York (RF SUNY). The grant, awarded on July 23, 2024, will support research to identify the hepatic epigenomic adaptations to excessive early-life cholesterol exposure due to maternal hypercholesterolemia, and evaluate the efficacy of maternal...